Literature DB >> 8806671

Phosphorylation of HIV-1 Rev protein: implication of protein kinase CK2 and pro-directed kinases.

F Meggio1, D M D'Agostino, V Ciminale, L Chieco-Bianchi, L A Pinna.   

Abstract

HIV-1 Rev transactivator is readily phosphorylated at separate regions by protein kinase CK2 and MAP kinase. Protein kinase CK1 cannot replace CK2 as phosphorylating agent and cdc2 only slowly phosphorylates Rev at one of the two sites affected by MAP kinase. Mutational analysis shows that Ser-8 and, to a lesser extent, Ser-5 are phosphorylated by CK2. In contrast, a mutation (R14TV-->EED) which suppresses Rev activity dramatically enhances Rev phosphorylation either in vitro by CK2 or in vivo, suggesting that phosphorylation by CK2 could play a role in Rev down-regulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806671     DOI: 10.1006/bbrc.1996.1392

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  HIV-1 Rev transactivator: a beta-subunit directed substrate and effector of protein kinase CK2.

Authors:  F Meggio; O Marin; M Boschetti; S Sarno; L A Pinna
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

2.  Identification of a domain in human immunodeficiency virus type 1 rev that is required for functional activity and modulates association with subnuclear compartments containing splicing factor SC35.

Authors:  D M D'Agostino; T Ferro; L Zotti; F Meggio; L A Pinna; L Chieco-Bianchi; V Ciminale
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology.

Authors:  Sheila A Barber; Linda Bruett; Brian R Douglass; David S Herbst; M Christine Zink; Janice E Clements
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Quantitative Temporal Viromics of an Inducible HIV-1 Model Yields Insight to Global Host Targets and Phospho-Dynamics Associated with Protein Vpr.

Authors:  John D Lapek; Mary K Lewinski; Jacob M Wozniak; John Guatelli; David J Gonzalez
Journal:  Mol Cell Proteomics       Date:  2017-06-12       Impact factor: 5.911

5.  Identification of a novel protein interaction motif in the regulatory subunit of casein kinase 2.

Authors:  Jennifer Yinuo Cao; Kathy Shire; Cameron Landry; Gerald D Gish; Tony Pawson; Lori Frappier
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

6.  Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design?

Authors:  Tulio de Oliveira; Marco Salemi; Michelle Gordon; Anne-Mieke Vandamme; Estrelita Janse van Rensburg; Susan Engelbrecht; Hoosen M Coovadia; Sharon Cassol
Journal:  Genetics       Date:  2004-07       Impact factor: 4.562

Review 7.  Protein kinase CK2: a potential therapeutic target for diverse human diseases.

Authors:  Christian Borgo; Claudio D'Amore; Stefania Sarno; Mauro Salvi; Maria Ruzzene
Journal:  Signal Transduct Target Ther       Date:  2021-05-17

8.  Phosphorylation events during viral infections provide potential therapeutic targets.

Authors:  Julie A Keating; Rob Striker
Journal:  Rev Med Virol       Date:  2011-11-24       Impact factor: 6.989

9.  HIV protein sequence hotspots for crosstalk with host hub proteins.

Authors:  Mahdi Sarmady; William Dampier; Aydin Tozeren
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

10.  Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2.

Authors:  Shu Liu; David Hsieh; Yi-Lin Yang; Zhidong Xu; Csaba Peto; David M Jablons; Liang You
Journal:  BMC Pharmacol Toxicol       Date:  2013-07-11       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.